Risk-Benefit Assessment [resa]
Tamoxifen [orch, phsu]
therapy [ftcn]
Endocrine [bdsy]
treatment [ftcn]
choice [inbe]
Women [popg]
Responsive [ftcn]
Breast Cancer [neop]
experience [menp]
Laboratory [mnob, orgt]
Clinical setting [spco]
Tamoxifen [orch, phsu]
effectiveness treatment [qlco]
Adjuvant [chvf]
Minor [popg]
Short-term [tmco]
adverse effects [ftcn]
therapeutic use [topp]
Extended [ftcn]
Clinical Trials [resa]
Begin [tmco]
Effectiveness [qlco]
Tamoxifen [orch, phsu]
Preventive treatment [topp]
Concern [idcn]
adverse effects [ftcn]
justify [ftcn]
Tamoxifen [orch, phsu]
Estrogen [horm, phsu, strd]
influential [idcn]
skeletal [bdsy]
Systems, Cardiovascular [bdsy]
decreases [qnco]
Postmenopausal Bone Loss [dsyn]
Low density lipoprotein [aapp, bacs, lipd]
effects [qlco]
Hope [menp]
decreases [qnco]
Incidences [qnco]
Osteoporosis [dsyn]
coronary heart disease [dsyn]
Morbidity [qnco]
Mortality [qnco]
postmenopausal [tmco]
Age Group [aggp]
Tamoxifen [orch, phsu]
therapy [ftcn]
Decreased [qnco]
contralateral breast cancer [neop]
long-term treatment [hlca]
Tamoxifen [orch, phsu]
Small [qnco]
Endometrial [spco]
Million [qnco]
Women [popg]
Take [hlca]
Tamoxifen [orch, phsu]
Long [qlco]
Small [qnco]
increases [ftcn]
translate [ocac]
Women [popg]
At risk [qlco]
Tamoxifen [orch, phsu]
Short-term [tmco]
treatment [ftcn]
Decision [menp]
Tamoxifen [orch, phsu]
Make [ftcn]
Benefits [qnco]
Tamoxifen [orch, phsu]
treatment [ftcn]
